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Abstract  1 
There is a growing appreciation that it is not just the total intake of dietary selenium (Se) 2 
that is important to health but that the species of Se ingested may also be important.  This review 3 
attempts to catalogue what is known about Se species in food sources and supplements and the 4 
health effects in which they are implicated.  The biosynthetic pathways involved in Se assimilation 5 
by plants and the way in which Se species are metabolized in animals are presented in order to give 6 
an insight into the species likely to be present in plant and animal foods.  Known data on the species 7 
of Se in the food chain and in food supplements are tabulated along with their concentrations and 8 
the analytical methodology used.   The latter is important since identification that is only based on 9 
retention time matching with authentic standards must be considered as tentative: for evidence of 10 
structural confirmation, fragmentation of the molecular ion in addition to MS data is required.  11 
Bioavailability, as normally defined, is higher for organic Se species.   Health effects, both 12 
beneficial and toxic, thought to be associated with specific Se species are described.  Potent anti-13 
tumour effects have been attributed to the low-molecular-weight species, Se-methyl-selenocysteine 14 
and its γ-glutamyl-derivative, found in a number of edible plants of the Allium and Brassica 15 
families.  There remain considerable gaps in our knowledge of the forms of Se that naturally occur 16 
in foods.  Without adequate knowledge of Se speciation, false conclusions may be drawn when 17 
assessing Se requirements for optimal health.  18 
 19 
 20 
 3
The extent of the literature on the essential trace element selenium (Se) appears to have increased 1 
exponentially over the last decade reflecting the tremendous growth of interest in this nutrient since 2 
it was shown by Clark and co-workers to reduce cancer risk in their landmark trial1.  Though the 3 
form of Se used in that trial was high-Se yeast, when large-scale funding was obtained from the 4 
National Cancer Institute for a follow-up randomized trial of the effect of supplemental Se on 5 
prostate cancer risk (SELECT), the decision was taken to use selenomethionine (SeMet) owing to 6 
the perceived importance of being able to define the specific form of Se that might be associated 7 
with an important health effect2.  Thus we are no longer satisfied with knowing simply the amount 8 
of Se that may be associated with benefit but seek to know the species of Se to which that alleged 9 
benefit may be attributed.  Furthermore, we have come to realize that different species of an 10 
element (viz. arsenic) can have very different health effects.  This review therefore attempts to pull 11 
together what is known about the species of Se in foods and supplements, the pathways by which 12 
they are synthesized, their apparent bioavailability as found in different food sources as this has 13 
implications for Se requirements, and the health effects that can be ascribed to specific Se species.    14 
  15 
 16 
Biosynthesis and metabolism of dietary Se species 17 
A consideration of Se speciation in plant and animal food sources requires some understanding of 18 
the biosynthetic pathways involved in Se assimilation by plants and how these species are 19 
metabolized in animals.  Such knowledge enables us to predict to some extent the Se species likely 20 
to be contained in foods.  The biosynthetic pathways for Se in plants, some of which are assumed 21 
by analogy with S pathways, are shown in Figure 1 (adapted from references3-8).  The relative 22 
dominance of the pathways differs for Se-accumulators and non-accumulators.  23 
  The major species in plant sources of Se are:- selenate (translocated directly from the soil 24 
and less-readily bound to soil components than selenite); SeMet (biosynthesised) and a smaller 25 
amount of SeCys (biosynthesised); Se-containing proteins (where SeMet and SeCys have been  26 
incorporated non-specifically in place of methionine and cysteine); Se-methyl-selenocysteine and γ-27 
glutamyl-Se-methyl-selenocysteine (considered as detoxification products, notably formed in Se-28 
accumulators and plants of the Brassica and Allium families).  Plants can volatilize significant 29 
amounts of Se as dimethylselenide (non-accumulators) and dimethyldiselenide (accumulators)6.  To 30 
avoid an over-complicated figure, the enzymes implicated in these pathways are not shown, with 31 
the exception of SeCys methyltransferase, the enzyme notably present in Se-accumulators and 32 
responsible for the methylation of SeCys to the characteristic methylated metabolites which are 33 
believed to have anti-cancer properties. 34 
 4
 While a study of these pathways suggests Se species that may be expected in foods from 1 
plant sources, it should be noted that compounds formed and their relative quantities differ not only 2 
between Se-accumulators and non-accumulators but also between species.  3 
 There is much less information on the species of Se in dietary sources of animal origin9.  4 
When inorganic Se is given to animals, SeCys is the main seleno-compound formed but when 5 
animals eat Se-containing foods of plant origin, protein-bound SeMet will also be formed from the 6 
non-specific incorporation of plant-derived SeMet in place of methionine.  Selenotrisulphide (-SeS-7 
), glutathione selenopersulphide (GSSeH) and metallic selenides have also been reported in 8 
tissues10.  The presence of some of these compounds can be explained by the metabolic pathway of 9 
dietary Se in animals which resembles that in humans as described below. 10 
 Most of what we know about the metabolism of dietary (or supplement) Se in humans is 11 
inferred from studies in rats and mice.  A simplified version of the metabolic pathway is shown in 12 
Figure 2 and clearly illustrates the central role of hydrogen selenide (H2Se) (adapted from11,12)13,14.  13 
SeMet catabolised from proteins can be trans-selenated to SeCys (by analogy with the trans-14 
sulphuration pathway).  SeCys, either from this source or directly from the diet, is then converted to 15 
H2Se by selenocysteine β-lyase.  Alternatively, SeMet can undergo α,γ-elimination catalysed by a 16 
γ-lyase to yield CH3SeH, though the relative importance of this route in humans is not known13,15,16.  17 
CH3SeH is also produced by a β-lyase from plant sources containing Se-methyl-selenocysteine and 18 
γ-glutamyl-Se-methyl-selenocysteine.  Utilisation of selenate or selenite (plant sources or 19 
supplements) for selenoprotein synthesis, or excretion of excess, first requires reduction to the 20 
central Se metabolite, H2Se, via interaction with the tripeptide, glutathione (GSH).  The H2Se so 21 
formed may be converted to selenophosphate (HSePO32-) which then reacts with tRNA-bound 22 
serinyl residues to give selenocysteine-bound tRNA from which selenocysteine is inserted co-23 
translationally, at loci encoded by specific UGA codons, to give selenoproteins17,18.  As CH3SeH 24 
can be demethylated to H2Se in an equilibrium reaction, both it and its precursors can also act as Se 25 
sources for selenoprotein synthesis13.  Oxidation of excess H2Se can lead to the production of 26 
superoxide and other reactive oxygen species with associated toxic effects11.   27 
 Surplus Se is transformed to methylated metabolites mostly for excretion into urine.   28 
Excretion of Se is either from H2Se through a methylated selenosugar (1β-methylseleno-N-acetyl-29 
D-galactosamine) in urine or by further methylation of CH3SeH to dimethyl selenide [(CH3)2Se] 30 
which is exhaled in breath, and trimethyl selenonium ion [(CH3)3Se+] excreted in urine19-21.  Though 31 
1β-methylseleno-N-acetyl-D-galactosamine is the most significant urinary metabolite in most 32 
individuals, (CH3)3Se+ is a major product from Se-methyl-selenocysteine13,21. 33 
 34 
 35 
 5
Se in food sources and dietary supplements: speciation and concentration  1 
Table 1 shows the Se species apparently identified in foods and dietary supplements and their 2 
concentrations or relative concentrations in some cases.    In terms of identification, it must be 3 
borne in mind that many of these studies were carried out when the available analytical strategies 4 
that combined both elemental and molecular mass spectrometry were less-well developed than is 5 
currently the case.   In the case of most foods, however, it is the only data we have and can help 6 
focus the direction of further studies.    Column 5 shows the methodology used for Se species 7 
identification.  Readers should be aware, however, that identification that is only based on retention 8 
time matching with authentic standards by HPLC-ICP-MS is tentative and that ESI-MS 9 
(electrospray ionisation mass spectrometry) data alone does not provide enough evidence of 10 
structural confirmation.  To obtain this, fragmentation of the molecular ion has to be performed28.  11 
The table contains some speciation data that have been obtained in this way e.g. by ICP-MS 12 
combined with MS/MS data obtained by MALDI (matrix assisted laser desorption/ionization) or 13 
ESI MS/MS (electrospray ionisation mass spectrometry with fragmentation of the 14 
precursor/molecular ion)27,30,31,32,33,37,47,48,56,57,58,61,62.   Those wishing to understand more about 15 
speciation-analysis methodology are referred to critical reviews of recent analytical developments 16 
for the Se speciation analysis of foods, supplements and bio-samples28,73. 17 
 Most quantitative data in this table have been calculated from the peak area for a particular 18 
Se species expressed as a percentage of the total area of eluted Se peaks.  However, accurate 19 
measurements by isotope dilution mass spectrometry or standard additions are also reported for 20 
methylated Se compounds such as SeMet and γ-glutamyl-Se-methyl-selenocysteine25,27,29,72.  21 
Ideally, full mass balance data (i.e. total selenium, total extracted selenium, selenium species, sum 22 
of species, extraction efficiency) should be considered together with recovery results from spiking 23 
experiments or analysis of “speciated” certified reference materials for validation of speciation 24 
methodologies. 25 
 The total Se concentration has been reported in the table where possible, as it can affect the 26 
distribution of Se between species, as in the case of Se-enriched garlic and yeast23.  As the 27 
concentration of Se in Se-enriched foods is considerably higher that in the corresponding natural 28 
foods, such foods must be treated with caution, though the amounts in which they are eaten (e.g. 29 
garlic) may reduce the risk of toxicity.   30 
 It is noteworthy that while wheat, other grains and soy contain predominantly SeMet with 31 
lesser amounts of SeCys and selenate, the major seleno-aminoacids found in Allium and Broccoli 32 
species are Se-methyl-selenocysteine and γ-glutamyl-Se-methyl-selenocysteine.  The latter two 33 
compounds are characteristic of the Se species produced by Se-accumulator plants which avoid the 34 
 6
toxic effects of incorporation of excessive amounts of SeCys and SeMet into their proteins by 1 
accumulating non-protein selenoamino acids or their γ-glutamyl derivatives6.  Other nonprotein 2 
selenoaminoacids that have been identified in selenium accumulator plants are selenocystathionine, 3 
Se-methyl-selenomethionine, γ-glutamyl-selenocystathionine, selenopeptides and 4 
selenohomocysteine9 though of these, only selenocystathionine has been fully identified in foods 5 
(Table 1).  6 
 Given that Brazil nuts are potentially the richest food source of Se, and the tree that 7 
produces them, Bertholletia excelsa, is regarded as a Se-accumulator, it might be expected that the 8 
major Se species would be Se-methyl-selenocysteine or gamma-glutamyl-Se-methyl-9 
selenocysteine, as described above.  Instead the major species in Brazil nuts appears to be SeMet 44-10 
46.  This may to some extent be an illustration of the differences in concentration and speciation 11 
found between different plant tissues, Brazil nuts being seeds rather than fleshy leaves or florets as 12 
in the case of garlic or broccoli3,6. However, it may also be due to more general differences in Se 13 
metabolism between plant species (personal communication, Dr Martin Broadley, 2007). 14 
 Considerably less information is available on Se species in animal foods than is available for 15 
plant foods.  Although the Se content of fish and other sea-foods has been reviewed by Reilly74, 16 
normally ranging from 0.1-1.0 µg/g fresh weight, there is little information on specific Se species in 17 
fish.  Several studies have found that sea-food Se appears to be less bioavailable than that from 18 
other dietary sources, the implication being that the molecular form of at least some of the fish Se is 19 
such that it is not utilisable for selenoprotein synthesis 40,75,76.  Though it has been suggested that an 20 
explanation for this lower bioavailability may be interaction with mercury (Hg) in sea-food, the 21 
molar concentration of Se exceeds that of Hg by one or two orders of magnitude except in the case 22 
of sea-mammals (cetaceans) suggesting that this is an unlikely explanation77-79.  While Se and Hg 23 
undoubtedly have very high affinity for one another80, there is as yet no published data identifying 24 
Se-Hg species in sea-food.  However, according to Dr Nick Ralston (personal communication 2007) 25 
it appears that inorganic HgSe is present in the muscle meat of blue marlin as has already been 26 
shown in organs of mammals81.  SeMet was the only compound identified in fish samples of high 27 
Se content in a speciation study67 though other studies found from 4-47% of total fish Se in the form 28 
of selenate 68-70.  This is an area ripe for further speciation studies.   29 
Recently, new Se-containing glutathione (GSH) species, S-selenomethyl-glutathione and 30 
glutathione-S-selenoglutathione (GS-SeG) have been identified in aqueous extracts of Se-yeast33.  31 
As shown in Figure 3, bonding of Se to GSH via a non-enzymatic reaction occurs in metabolism at 32 
the point where selenite enters the pathway to SeCys6.  Alternatively, as glutathione is a tripeptide 33 
of γ-glutamine, cysteine and glycine, it seems possible that the formation of these Se-containing 34 
 7
GSH species could result from the incorporation of selenocysteine (or methylated selenocysteine) in 1 
place of cysteine in the biosynthetic pathway to glutathione.   2 
 While on the subject of Se-yeast, we should make it clear that it is not a defined form of Se.  3 
There is considerable variability in products described as Se-yeast which is reflected in the species 4 
composition.  Se-yeast is produced by fermenting yeast in a Se-enriched medium when the Se 5 
becomes organically bound to yeast components.  With reputable manufacturers, the percentage of 6 
Se that is organically bound should be greater than 90% and more than 80% should be bound to 7 
yeast proteins, including cell-wall proteins12.  However, in some products, the percentage of sodium 8 
selenite is such that most of the selenium is clearly not bound to the yeast: at worst, there may 9 
merely be a mixture of sodium selenite and yeast, the selenium not being bound to the yeast24.   10 
Such products dupe the consumer as they do not conform to the normal understanding of Se-yeast 11 
as containing Se in an organic form.  While they may be capable of increasing the production of 12 
selenoproteins, they will be less-good at increasing plasma Se and acting as a storage form of Se in 13 
the body (see below) thereby maintaining Se status82. 14 
 15 
Se in food sources and dietary supplements: bioavailability 16 
Bioavailability of a nutrient is conventionally defined as that fraction of ingested nutrient that is 17 
utilised for normal physiological functions83: absorption and retention of the nutrient are taken as 18 
indirect measures of bioavailability as these are measurable83 though they cannot address functional 19 
bioavailability which is that most likely to be relevant to health.   20 
 Absorption of Se is not homeostatically regulated and is not believed to be affected by 21 
nutritional status.  Absorption of dietary Se is generally believed to be good - around 80% from 22 
food74.  Guar gum is thought to reduce its absorption in humans84 as is high dietary sulphur, 23 
probably because of competition between chemically similar sulphur and Se species74, 85.  24 
Absorption of SeMet is active and uses the same enzyme transport system as does methionine74.  25 
Absorption and retention of a commercially-produced Se-yeast in which 66% of the Se present was 26 
in the form of SeMet (SelenoPrecise™), were measured as 90% and 75% respectively (see12)86. 27 
 A number of supplementation studies have compared the bioavailability of different forms 28 
of Se to humans, i.e. Se-rich wheat, Se-enriched yeast, SeMet, sodium selenate and sodium selenite 29 
(see review12).  Organic forms of Se (wheat Se, SeMet and high Se-yeast) were found to be more 30 
bioavailable than selenate and selenite in that they were more effective in raising blood Se 31 
concentrations (suggesting better absorption and retention), though all forms were able to increase 32 
selenoenzyme (glutathione peroxidase) activity.  This difference is undoubtedly due to the ability of 33 
SeMet from digested organic Se sources to be incorporated in place of methionine into tissue 34 
proteins such as skeletal muscle, erythrocytes and plasma albumin where it can act as a Se store 35 
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though it becomes available to the body only upon turnover of tissue proteins87.  Organic Se (Se-1 
yeast) was also more effective than inorganic forms in its ability to transfer Se to breast-fed infants 2 
or suckling animals, thereby reducing the risk of deficiency in the offspring12 .  Foods that contain 3 
high proportions of SeMet, such as Brazil nuts and wheat, are good bioavailable sources of the 4 
element88,89.  Though the Se content of mushrooms is higher than that of most other vegetables74, its 5 
bioavailability is said to be very low90.  However, our own recent work on Se-enriched mushrooms 6 
shows SeMet to be the major Se species and bioavailability to be good57.  A speciation effect may 7 
be responsible for the bioavailability of Se from fish being inconsistent91: one study has shown a 8 
daily intake of 115 µg Se from fish to be unable to increase Se status76.   9 
 There is good evidence that the increased Se status attained after supplementation with 10 
organic forms of Se is retained for a longer period after supplementation has ceased than is the case 11 
with selenite or selenate12.  Reported whole-body half-lives of SeMet and selenite in humans were 12 
252 and 102 days respectively, implying that Se administered as SeMet is retained 2.5 times longer 13 
in the body than is selenite85.  Accordingly, foods or supplements containing SeMet can maintain 14 
the activities of selenoenzymes during Se depletion for longer periods of time than those containing 15 
inorganic Se owing to the recycling of SeMet catabolised from protein stores85.   16 
 No bioavailability data exist for Se-methyl-selenocysteine or γ-glutamyl-Se-methyl-17 
selenocysteine. 18 
 19 
 20 
Health effects associated with specific Se species in foods and supplements 21 
While the nutritionally essential functions of Se are understood to be fulfilled by the selenoproteins, 22 
dietary Se can be metabolized to small molecular weight species that have more recently generated 23 
interest because of putative anti-cancer effects.  In contrast to such beneficial effects, at a 24 
sufficiently-high dose level, Se metabolites can also cause toxicity. 25 
 26 
Species-related beneficial effects 27 
Though supplementation with Se or a good Se intake or status has been associated with health 28 
benefits, there is little or no evidence to connect such benefits with particular Se species.  We know 29 
from studies in transgenic mice that selenoproteins are important for the cancer-protective effects of 30 
selenium92 and it seems likely that antioxidant selenoproteins may be of benefit in counteracting 31 
diseases of oxidative stress.  However, selenoproteins can be synthesised more or less efficiently 32 
from many different Se species, though if consumed in foods, they are digested and must be 33 
resynthesised as shown in Fig. 2.   34 
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In mice with genetically impaired selenoprotein expression, the presence of low molecular 1 
weight selenocompounds has been shown to reduce colon cancer risk92.  Such low-molecular 2 
weight selenocompounds may be an in vivo source of the methylated metabolite, CH3SeH which is 3 
believed to be responsible for the potent anti-carcinogenic and anti-angiogenic effects of Se shown 4 
in the rat mammary tumour model and in cells in culture5,60,93-97.  As shown in Fig 2 and explained 5 
above, CH3SeH can be formed directly from the low-molecular weight selenocompounds, Se-6 
methyl-selenocysteine, by the action of a β-lyase11 and SeMet by the action of a γ-lyase, also known 7 
as methioninase13,15,16,97-99.   8 
 Se-methyl-selenocysteine and its γ-glutamyl-derivative are found in a number of edible 9 
plants, including garlic, onions and broccoli and others of the Allium and Brassica  families, 10 
particularly when grown in Se-enriched conditions5,23,60.  Se-enriched plants such as broccoli and 11 
garlic have been shown to have potent anti-tumour effects in animals that are attributed to the 12 
presence of these species60,96.  Though these species have not yet been tested in human 13 
interventions, a number of groups are planning pharmacokinetic studies as a prelude to human trials 14 
(Dr Clement Ip, personal communication, 2006).  Small amounts of both Se-methyl-selenocysteine 15 
and γ-glutamyl-Se-methyl-selenocysteine have also been identified in Se-yeast which may possibly 16 
be relevant to the anti-cancer effects seen in human trials with Se-yeast26,27.  Se-methyl-17 
selenocysteine has been commercially available for some time and can be bought over-the-counter 18 
as a supplement. 19 
 Though there is as yet no evidence of it, it appears possible that Se analogues of anti-cancer 20 
sulfur compounds such as diallyldisulphide and ajoene may also be isolable from Se-enriched garlic 21 
or onions.  As diallylselenide was found to be more than 300-times more effective than 22 
diallylsulfide in protecting against carcinogen-induced mammary adenocarcinoma in rats97, 23 
attempts to find such species may be worthwhile.   24 
 25 
Species-related toxic effects 26 
More is known about species-related toxic effects of Se than about species-related beneficial 27 
effects.  The toxicity of Se and the mechanisms by which it exerts its toxic effects depend on its 28 
form though there is little species-specific data on the toxicity of Se in humans. 29 
It is likely that a number of different mechanisms are involved.  According to Spallholz and 30 
colleagues97, 98, Se compounds that can easily form the anion, RSe¯, generate superoxide in the 31 
presence of thiols such as GSH, resulting in redox cycling, cell-cycle arrest and apoptosis.  32 
Spallholz ascribes the toxic (and indeed the carcinostatic) effects of Se to this oxidative-stress 33 
mechanism.  Superoxide has been shown to be generated from selenite and diselenides such as 34 
selenocystamine in the presence of reduced GSH in vitro, though not from selenate, SeMet or Se-35 
 10
methyl-selenocysteine97.  Neither SeMet nor Se-methyl-selenocysteine is very toxic to cells in 1 
culture nor to animals or humans in line with their inability to generate superoxide, although both 2 
are capable of conversion to CH3SeH by enzymatic systems either in vitro or in vivo97.    3 
 Selenodiglutathione (GSSeSG), an intermediate in the formation of superoxide from selenite 4 
and GSH, has been found to be even more toxic than selenite itself98,99.  However, in contradiction 5 
to Spallholz’s belief, Harrison and colleagues100 did not find that the growth inhibition observed 6 
with this compound resulted from induction of an oxidative-stress mechanism, at least not of the 7 
type observed with oxidants such as H2O2.  Supporting an oxidative-stress mechanism, selenite-8 
induced redox cycles have been suggested to be responsible for oxygen-dependent DNA 9 
fragmentation in Se toxicity to hepatocyte model systems101 and high levels of selenite have been 10 
shown to induce the formation of 8-hydroxy-2-deoxyguanosine in rat liver DNA102.  11 
 Other suggested mechanisms of Se toxicity include inhibition of Se methylation, the major 12 
detoxification pathway for Se, allowing the accumulation of hepato-toxic selenides, notably H2Se.  13 
For instance, in mice, high doses of SeCys have been shown to cause hepatic toxicity by depressing 14 
Se methylation through the inactivation of methionine adenosyltransferase, the enzyme responsible 15 
for S-adenosyl methionine (SAM) synthesis103.   16 
 Although it has been suggested that organic forms of Se may be more toxic than inorganic 17 
forms during long-term consumption as they can be incorporated into tissue proteins rather than be 18 
excreted rapidly104, there is no evidence that this is the case40.  Long term supplementation studies 19 
with Se-yeast at doses of 200, 300, 400 and even 800 µg Se/d for lengthy periods (up to 12 years in 20 
the case of the 200 µg dose) have been carried out by a number of research groups without any 21 
indication of toxic effects (for references, see12).  Furthermore men with prostate cancer tolerated 22 
doses of 1600 and 3200 µg Se/d for almost 12 months “without any obvious Se-related serious 23 
toxicity”105.  Thus these results imply that uncontrolled accumulation of tissue Se does not occur.    24 
 Though there is no direct evidence in humans, it is generally accepted on the basis of animal 25 
studies that inorganic forms of Se are more acutely toxic than organic forms, selenite being slightly 26 
more toxic than selenate40.  Though of equivalent toxicity to SeCys in animals, sodium selenite is 27 
considerably more acutely toxic than SeMet, dimethyl selenide, trimethyl selenonium ion, 28 
selenoethers, selenobetaine or Se-yeast, the major Se component of which is SeMet40.   From LD50 29 
determinations, selenite was found to be four-fold more toxic than SeMet when administered to 30 
mice intravenously106 and three-fold more toxic than Se-yeast when given orally to rats107.   31 
 Chronic toxicity of SeCys is equivalent to that of selenite and both are more toxic than 32 
SeMet (the L-isomer of which is more toxic than the D-isomer) and other organic Se compounds in 33 
animal studies40.  Comparison of selenite and Se-yeast diets in rats showed that Se-yeast was much 34 
less toxic than selenite: although the livers of animals fed Se-yeast showed up to 50% greater 35 
 11
deposition of Se, there was no corresponding toxicity, as evidenced by histological examination108.  1 
Se-yeast also seems to be less toxic than L-SeMet: after two weeks of feeding 30 µg Se/g diet, 2 
survival in mallard ducklings was 36% for L-SeMet and 88% for Se-yeast109.  Human studies have 3 
also shown a lower chronic toxicity of organically-bound Se though there is limited data on the 4 
toxicity of individual compounds40.  However, SeMet is known to be the main Se species present in 5 
the diet of Chinese who developed chronic selenosis from consumption of corn and rice grown in 6 
the Enshi area of China39. 7 
 The toxicity of the Se-accumulators to livestock has been linked to the high levels of Se-8 
methyl-selenocysteine found in these species110.  Se-accumulator plants are able to circumvent the 9 
toxicity that would result from the non-specific integration of the selenoamino acids SeCys and 10 
SeMet into proteins by converting the precursor, SeCys, into the non-protein amino acids Se-11 
methyl-selenocysteine, γ-glutamyl-Se-methyl-selenocysteine and selenocystathionine8.  The potent 12 
toxicity of Se-accumulator plants to grazing animals is probably more a reflection of the extremely 13 
high concentrations of Se that can build up in these plants – up to 10 to15 mg Se/g dry weight even 14 
on non-seleniferous soils8 – rather than the toxicity of Se-methyl-selenocysteine per se.   According 15 
to Dr Clement Ip (personal communication 2006) who has worked with Se-methyl-selenocysteine 16 
for many years, it should be a safer compound than SeMet based on its biochemistry: though both 17 
compounds are equally well absorbed, Se-methyl-selenocysteine is converted to excretable 18 
metabolites more rapidly resulting in lower tissue retention of selenium.  Comparison of the 19 
NOAEL in male and female rats for Se-methyl-selenocysteine (1.0 and 0.5 mg/kg/day, respectively) 20 
with that for selenite (0.14 and 0.2 mg/kg/day, respectively) suggests that Se-methyl-selenocysteine 21 
is less toxic at least than selenite111 (Clement Ip, personal communication 2006).  Results from 22 
Hasegawa and colleagues103 similarly suggest that methylated forms of Se are generally less-toxic 23 
than non-methylated compounds.  This postulated lower toxicity may be highly relevant to the 24 
potential for use of Se-methyl-selenocysteine in human cancer prevention studies.   25 
 26 
 27 
Conclusion 28 
The development of state-of-the-art analytical methods that combine elemental and molecular mass 29 
spectrometric detection, to investigate different chemical forms of Se in food has made possible the 30 
identification of a variety of Se species in foods and supplements.  However, this is such a difficult 31 
and exacting area of research that to date, we have only scratched the surface.  It is difficult to 32 
maintain the integrity of species through the extraction process.  Though we may know the identity 33 
of some Se species present in foods, there is no case where we know the identity of all the Se 34 
species: only where we have mass balance, can we ensure that all species have been captured.  We 35 
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need to take food processing and preparation into account so that we are actually investigating the 1 
species that will be consumed (e.g. Japanese soup stock made from shiitake mushrooms56). 2 
There remain considerable gaps in our knowledge of the forms of Se that naturally occur in 3 
foods:- for instance we know little about species of Se, other than selenomethionine, in fish, 4 
normally considered a good source of the element, or indeed what Se-Hg species may be present; 5 
we need to know full speciation of Se in Se yeast because of its frequent use in human intervention 6 
studies; and perhaps most importantly, there is a need to know to which Se species beneficial or 7 
detrimental health effects can be attributed.  8 
We need to continue to develop speciation methodology, and to further investigate 9 
biosynthetic and metabolic pathways in order to have a steer on what species we should be 10 
searching for.  Where we do suspect we know the identity of an active species (e.g. Se-methyl-11 
selenocysteine), we need single-species trials to prove efficacy or relative efficacy to help us 12 
towards a better understanding of how dietary Se should be supplemented.   13 
Finally, there is a clear need for analytical chemists to present the data in a form that is 14 
understandable to and usable by consumers, nutritionists and legislators.  Without adequate 15 
knowledge of Se speciation, false conclusions may be drawn when assessing Se requirements for 16 
optimal health.  Furthermore, the ability to identify and accurately quantify Se species with 17 
powerful anti-cancer or other valuable effects will be essential for the development of plant 18 
breeding programmes to optimise the biosynthesis of such species if clear proof of their health 19 
effects should be forthcoming.   20 
 21 
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Figure legends  1 
 2 
Figure 1.  Biosynthetic pathways elucidated for Se in higher plants (some by analogy with S 3 
pathways) (adapted from references3-8).  Note: reactions vary from species to species so that 4 
compounds formed and their relative quantities differ between species and strains.  Abbreviations: 5 
APSe adenosine-5′-phosphoselenate; DMDSe dimethyl-diselenide (volatile); DMSe dimethyl 6 
selenide (volatile); DMSeP dimethyl-selenonio-propionate [CH3Se+(CH3)2CH2CH2COO-]; GSH 7 
glutathione; GSSeO32- glutathione-S-selenite; GSSeSG selenodiglutathione; GSSeH glutathione-8 
selenopersulphide; GSSe- glutathione-conjugated selenide; γ-GMeSeCys γ-glutamyl-Se-methyl-9 
selenocysteine; γ-GSeCysth γ-glutamyl-selenocystathionine; MeMet+ S-methyl methionine; MeSeH 10 
methyl selenol; MeSeCysSeO Se-methyl-selenocysteine selenoxide; MeSeCys Se-methyl-11 
selenocysteine; MeSeMet+ Se-methyl-selenomethionine; MeTHF methyl-tetrahydrofolate; SAM S-12 
adenosyl methionine; Se-ASeMet Se-adenosyl-selenomethionine; Se-Homocysteine 13 
selenohomocysteine; SeCysth Selenocystathionine. 14 
 15 
 16 
Figure 2.  Metabolic pathway of dietary Se in humans (adapted from11,12)13, 14.  Abbreviations: 17 
SeMet, selenomethionine; SeCys, selenocysteine; γ-glutamyl-CH3SeCys, γ-glutamyl-Se-methyl-18 
selenocysteine; CH3SeCys, Se-methyl-selenocysteine; H2Se, hydrogen selenide; CH3SeH, methyl 19 
selenol; (CH3)2Se dimethyl selenol; (CH3)3Se+ trimethyl selenonium ion; GSSeSG 20 
selenodiglutathione; HSePO32-, selenophosphate; SeO2, selenium dioxide. 21 
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